URINALYSIS POLICY UPDATE:
1 NAVADMINs are known that
refer back to this one:
R 272107Z MAR 20 MID110000530450U
FM CNO WASHINGTON DC
INFO CNO WASHINGTON DC
PASS TO OFFICE CODES:
FM CNO WASHINGTON DC//N1//
INFO CNO WASHINGTON DC//N1//
MSGID/GENADMIN/CNO WASHINGTON DC/N1/MAR//
SUBJ/URINALYSIS POLICY UPDATE//
NARR/ REF A IS OPNAVINST 5350.4D, NAVY ALCOHOL AND DRUG ABUSE
PREVENTION AND CONTROL. REF B IS CENTER FOR DISEASE CONTROL (CDC)
COVID-19 HOW TO PROTECT YOURSELF AVAILABLE AT
RMKS/1. This NAVADMIN announces a temporary amendment to the Navy
urinalysis program to minimize Sailor exposure to Coronavirus-19
(COVID-19) and adhere to social distancing requirements.
2. Commands will continue random urinalysis specimen collection
from Sailors during the COVID-19 pandemic to the greatest extent
possible. Commanders and Commanding Officers may pause collection
and/or reduce collection percentages and numbers of days collected
if he/she deems it necessary to support maximum operational
flexibility and/or COVID-19 mitigation efforts.
a. Drug testing shall be conducted with no more than 10 people,
including the urinalysis program coordinator (UPC) and observer,
gathering for testing in one place at one time while maintaining
social distancing of six feet at all times while continuing to
follow all collection procedures outlined in reference (a).
b. All command-directed, probable cause, mishap investigations
and rehabilitation testing will continue in accordance with
c. Commands shall not recall individuals who are sick,
restricted in movement (ROM), quarantined or self-monitoring and
should not recall individuals who are teleworking or in a non-duty
status to provide a drug testing specimen.
d. Navy Drug Screening Laboratories (NDSL) will continue to
operate and test these specimens.
3. Sailors assigned to non-Navy activities will follow the policy
of those activities.
4. As a result of this temporary policy change, the requirement in
paragraph 6.a., enclosure (2) of reference (a) to provide their
echelon 3 commander with the reason for failing to comply with
reference (a) is suspended until further notice.
5. Care must continue to be taken when conducting random urinalysis
collections. According to the Centers for Disease Control (CDC), it
is not known whether non-respiratory body fluids such as urine can
contain the virus. The CDC indicates interpersonal contact
continues to present the greatest risk of COVID-19 exposure. Please
adhere to the following processes to mitigate risks to exposure
during urinalysis collections in line with reference (b).
a. All urinalysis specimen collection testing shall comply with
all current OPNAV policies and CDC Health Guidance.
b. All participants must engage in safe hygiene practices,
including hand washing, maintaining the six feet social distancing
requirement, and refraining from touching their face.
c. Administrators shall wipe down all surfaces contacted (after
each contact) throughout collection to include tables and door
d. UPCs will not handle a specimen bottle after it has been in
the possession/control of the Sailor. Sailors providing a specimen
will tighten the lids securely to avoid cross contamination, adhere
labels, affix security tape on the specimen bottle and place their
specimen bottle in a secondary container with absorbent materials
under the observation and direction of the UPC. Sailors should use
their own pen to sign and initial during the process. Additionally,
UPCs should not handle the military identification card of the
e. Sailors, UPCs and observers must avoid personal touch and
wash their hands after any contact during this process. All must
avoid the exchange of personal items (i.e., identification cards,
6. For additional information or questions, the urinalysis program
point of contact is Ms. LaNorfeia Parker, OPNAV N170D, at (901) 874-
4249/DSN 882 or firstname.lastname@example.org.
7. This NAVADMIN will remain in effect until superseded or
canceled, whichever occurs first.
8. Released by Vice Admiral John B. Nowell, Jr, N1.//